| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
|
Cancer Res
|
2000
|
4.66
|
|
2
|
Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
|
N Engl J Med
|
2001
|
4.13
|
|
3
|
[Second Opinion Consult Clinic for Surgical Oncology in the Daniel den Hoed Clinic: analysis of the first 245 patients].
|
Ned Tijdschr Geneeskd
|
1999
|
2.56
|
|
4
|
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.
|
Cancer Res
|
2000
|
2.09
|
|
5
|
A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group.
|
J Clin Pathol
|
1997
|
1.76
|
|
6
|
Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB.
|
Radiology
|
1996
|
1.59
|
|
7
|
Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic method.
|
World J Surg
|
1997
|
1.48
|
|
8
|
Antibodies to components of neutrophil cytoplasm: a new diagnostic tool in patients with Wegener's granulomatosis and systemic vasculitis.
|
Q J Med
|
1988
|
1.47
|
|
9
|
[Endometriosis of the rectum].
|
Ned Tijdschr Geneeskd
|
1993
|
1.37
|
|
10
|
The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters.
|
Eur J Cancer
|
1996
|
1.34
|
|
11
|
Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration.
|
J Neurol Neurosurg Psychiatry
|
1993
|
1.33
|
|
12
|
Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources.
|
Int J Cancer
|
1996
|
1.13
|
|
13
|
Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous system.
|
J Neurol Neurosurg Psychiatry
|
1990
|
1.13
|
|
14
|
Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components. European BIOMED-1 Concerted Action on Clinical Relevance of Proteases in Tumour Invasion and Metastasis.
|
Eur J Cancer
|
1998
|
1.13
|
|
15
|
Prognostic significance of cathepsins B and L in primary human breast cancer.
|
J Clin Oncol
|
1998
|
1.12
|
|
16
|
Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients.
|
Arthritis Rheum
|
1990
|
1.11
|
|
17
|
Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.
|
Br J Cancer
|
2001
|
1.08
|
|
18
|
The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.
|
Br J Cancer
|
1997
|
1.05
|
|
19
|
Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer.
|
Int J Cancer
|
1992
|
1.05
|
|
20
|
Stromal influences on breast cancer cell growth.
|
Br J Cancer
|
1992
|
1.03
|
|
21
|
Neurone-specific enolase and S-100: new markers for delineating the innervation of the respiratory tract in man and other mammals.
|
Thorax
|
1983
|
1.00
|
|
22
|
The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study.
|
Eur J Cancer
|
1993
|
0.98
|
|
23
|
The value of ultrasound with ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neck.
|
Int J Radiat Oncol Biol Phys
|
1998
|
0.97
|
|
24
|
Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.
|
Am J Pathol
|
1994
|
0.97
|
|
25
|
Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.
|
Int J Cancer
|
1992
|
0.97
|
|
26
|
Angiosarcoma of the breast following lumpectomy, axillary lymph node dissection, and radiotherapy for primary breast cancer: three case reports and a review of the literature.
|
Int J Radiat Oncol Biol Phys
|
1993
|
0.95
|
|
27
|
Quality control of immunocytochemical staining of effusions using a standardized method of cell processing.
|
Acta Cytol
|
1996
|
0.95
|
|
28
|
Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer.
|
Int J Cancer
|
1995
|
0.94
|
|
29
|
Discrepancy between second and first opinion in surgical oncological patients.
|
Eur J Surg Oncol
|
2005
|
0.93
|
|
30
|
Simultaneous immunoenzyme staining of vimentin and cytokeratins with monoclonal antibodies as an aid in the differential diagnosis of malignant mesothelioma from pulmonary adenocarcinoma.
|
Virchows Arch B Cell Pathol Incl Mol Pathol
|
1986
|
0.93
|
|
31
|
Influence of fixation and decalcification on the immunohistochemical staining of cell-specific markers in paraffin-embedded human bone biopsies.
|
J Histochem Cytochem
|
1985
|
0.92
|
|
32
|
Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue.
|
Int J Biol Markers
|
2001
|
0.91
|
|
33
|
Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures.
|
FEBS Lett
|
1998
|
0.91
|
|
34
|
Antineuronal antibodies in patients with neurologic complications of primary Sjögren's syndrome.
|
Neurology
|
1993
|
0.91
|
|
35
|
Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication.
|
Cancer
|
1994
|
0.91
|
|
36
|
Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer.
|
J Steroid Biochem Mol Biol
|
1990
|
0.90
|
|
37
|
Expression of the gene encoding growth hormone in the human mammary gland.
|
J Clin Endocrinol Metab
|
1995
|
0.89
|
|
38
|
Prognostic value of CD44 variant expression in primary breast cancer.
|
Int J Cancer
|
1999
|
0.89
|
|
39
|
Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue.
|
Virchows Arch A Pathol Anat Histopathol
|
1987
|
0.88
|
|
40
|
Anti-neuronal antibodies in paraneoplastic neurological disorders with small-cell lung carcinoma.
|
Clin Neurol Neurosurg
|
1990
|
0.88
|
|
41
|
Ki-67 staining in histological subtypes of breast carcinoma and fine needle aspiration smears.
|
J Clin Pathol
|
1991
|
0.88
|
|
42
|
Immunocytochemical detection of prognostic markers in breast cancer; technical considerations.
|
Cytopathology
|
1999
|
0.87
|
|
43
|
Genetic alterations in ovarian borderline tumours and ovarian carcinomas.
|
Eur J Obstet Gynecol Reprod Biol
|
1999
|
0.86
|
|
44
|
Cytokine-regulated urokinase-type-plasminogen-activator (uPA) production by human breast fibroblasts in vitro.
|
Breast Cancer Res Treat
|
1999
|
0.85
|
|
45
|
Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumors.
|
Int J Cancer
|
1996
|
0.85
|
|
46
|
High prevalence of codon 213Arg-->Stop mutations of the TP53 gene in human ovarian cancer in the southwestern part of The Netherlands.
|
Int J Cancer
|
1998
|
0.85
|
|
47
|
Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.
|
Br J Cancer
|
1996
|
0.84
|
|
48
|
Axillary nodal metastases from an occult primary consistent with breast carcinoma.
|
Br J Surg
|
1993
|
0.84
|
|
49
|
Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control.
|
Eur J Surg Oncol
|
2000
|
0.82
|
|
50
|
Carcinoma of unknown primary: identification of a treatable subset?
|
Ann Oncol
|
1990
|
0.82
|
|
51
|
Postinfantile giant cell hepatitis in a patient with multiple autoimmune features.
|
Am J Gastroenterol
|
1985
|
0.81
|
|
52
|
Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast.
|
J Pathol
|
1999
|
0.81
|
|
53
|
Transforming growth factor beta secretion from primary breast cancer fibroblasts.
|
Mol Cell Endocrinol
|
1995
|
0.80
|
|
54
|
Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement.
|
Eur J Surg Oncol
|
2006
|
0.80
|
|
55
|
Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence.
|
Br J Cancer
|
1995
|
0.80
|
|
56
|
A rapid and simple hapten conjugation method for monoclonal antibodies to be used in immunoenzyme single and double staining procedures.
|
J Immunol Methods
|
1987
|
0.79
|
|
57
|
Systemic and anti-neuronal auto-antibodies in patients with paraneoplastic neurological disease.
|
J Neurol
|
1996
|
0.79
|
|
58
|
The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primary.
|
J Cancer Res Clin Oncol
|
1996
|
0.78
|
|
59
|
Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis.
|
Br J Cancer
|
1990
|
0.77
|
|
60
|
Serous otitis media and immunological reactions in the middle ear mucosa.
|
Acta Otolaryngol
|
1989
|
0.77
|
|
61
|
Cervical cancer metastasising to the breast: report of two cases.
|
Eur J Surg
|
1993
|
0.77
|
|
62
|
Leucocytoclastic vasculitis as presenting feature of primary Sjögren's syndrome.
|
Clin Rheumatol
|
1994
|
0.77
|
|
63
|
Quantification of area percentage of immunohistochemical staining by true color image analysis with application of fixed thresholds.
|
Anal Quant Cytol Histol
|
1994
|
0.77
|
|
64
|
Relation between serological data at the time of biopsy and renal histology in lupus nephritis.
|
Rheumatol Int
|
1991
|
0.76
|
|
65
|
[Bronchial carcinoma with secondary amyloidosis as a cause of nephrotic syndrome].
|
Ned Tijdschr Geneeskd
|
1982
|
0.76
|
|
66
|
Anti-neuronal antibodies in Sjögren's syndrome and in paraneoplastic neurological disease.
|
Lancet
|
1994
|
0.75
|
|
67
|
Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2)
|
Br J Cancer
|
1990
|
0.75
|
|
68
|
Influence of hydrolysis products of aqua(1,1-bis(aminomethyl)cyclohexane)sulfatoplatinum(II) on toxicity in rats.
|
Cancer Lett
|
1984
|
0.75
|
|
69
|
Post-irradiation angiosarcoma of the greater omentum.
|
Eur J Surg Oncol
|
1989
|
0.75
|
|
70
|
Phase I studies of rodorubicin single bolus and daily times five, once every three weeks in patients with advanced solid tumors.
|
Eur J Cancer Clin Oncol
|
1989
|
0.75
|
|
71
|
Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary site.
|
Ann Oncol
|
1993
|
0.75
|
|
72
|
Thyroglossal cysts in patients over 30 years of age.
|
Int J Oral Maxillofac Surg
|
1987
|
0.75
|
|
73
|
Quantification of relative area of pS2 immunohistochemical staining and epithelial percentage in breast carcinomas: the effect of the latter on the interpretation of a cytosolic pS2 assay.
|
Mod Pathol
|
1995
|
0.75
|
|
74
|
Monoclonal antibodies in the histopathological diagnosis of non-Hodgkin lymphomas.
|
Neth J Med
|
1985
|
0.75
|
|
75
|
Immunocytochemical staining of effusions; an external quality control study in The Netherlands.
|
Cytopathology
|
1997
|
0.75
|